Madison-based Stratatech Corp. has received a federal grant of nearly $1 million it will use to work to enhance the ability of its engineered human skin products to promote the healing of chronic wounds.
….Stratatech’s products are based on a patented, unique source of pathogen-free human skin cells identified at the UW-Madison as being able to multiply indefinitely.